ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,00%
Bitcoin
67.036,72
-0,06%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Kaya Holdings Inc (QB) (KAYS)

  7. Kaya Holdings Inc (QB) (KAYS) News

KAYS

Kaya (QB) (KAYS)

Kaya Holdings Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:KAYS
DatumZeitQuelleÜberschriftSymbolFirma
16/05/202422h32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:KAYSKaya Holdings Inc (QB)
10/05/202414h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
15/02/202422h38Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:KAYSKaya Holdings Inc (QB)
28/11/202313h00InvestorsHub NewsWireInvestor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental HealthUSOTC:KAYSKaya Holdings Inc (QB)
20/11/202323h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:KAYSKaya Holdings Inc (QB)
09/11/202314h30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
23/10/202322h15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
03/10/202313h48Edgar (US Regulatory)Form 8-K - Current reportUSOTC:KAYSKaya Holdings Inc (QB)
21/08/202322h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:KAYSKaya Holdings Inc (QB)
14/08/202314h44Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:KAYSKaya Holdings Inc (QB)
24/05/202315h48InvestorsHub NewsWireKaya Holdings, Inc.'s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A.USOTC:KAYSKaya Holdings Inc (QB)
22/05/202322h07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:KAYSKaya Holdings Inc (QB)
19/05/202322h07Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:KAYSKaya Holdings Inc (QB)
15/05/202322h29Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:KAYSKaya Holdings Inc (QB)
15/05/202316h29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
27/04/202320h52Edgar (US Regulatory)Annual Report (10-k)USOTC:KAYSKaya Holdings Inc (QB)
13/03/202313h33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
21/02/202312h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
15/02/202314h45InvestorsHub BioTech NewsWireKaya Holdings, Inc. Psychedelics Subsidiary Taps Total Holistic Center ™ to Develop Ketamine Treatment Model for Launch of Fifth Dimension Therapeutics ™ Mind Care ClinicsUSOTC:KAYSKaya Holdings Inc (QB)
15/02/202314h45InvestorsHub NewsWireKaya Holdings, Inc. Psychedelics Subsidiary Taps Total Holistic Center ™ to Develop Ketamine Treatment Model for Launch of Fifth Dimension Therapeutics ™ Mind Care ClinicsUSOTC:KAYSKaya Holdings Inc (QB)
30/01/202314h32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
25/01/202316h53InvestorsHub NewsWireKaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics MarketUSOTC:KAYSKaya Holdings Inc (QB)
14/11/202221h57Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:KAYSKaya Holdings Inc (QB)
15/09/202222h08Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:KAYSKaya Holdings Inc (QB)
22/08/202222h07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:KAYSKaya Holdings Inc (QB)
04/08/202218h44InvestorsHub NewsWireKaya Holdings to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in OregonUSOTC:KAYSKaya Holdings Inc (QB)
07/07/202219h11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
30/03/202222h20Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:KAYSKaya Holdings Inc (QB)
29/12/202120h44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:KAYSKaya Holdings Inc (QB)
22/11/202118h40Edgar (US Regulatory)Quarterly Report (10-q)USOTC:KAYSKaya Holdings Inc (QB)
 Showing the most relevant articles for your search:USOTC:KAYS

Kürzlich von Ihnen besucht

COIN
ACATETH
Alphacat
COIN
B24GBP
ASX
LTFHA
La Trobe Financial Capit...
NASDAQ
FRHWSX
Income Dividend Equity A...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten